Appreciate the info. I have a rule that if I really want a stock...

First 17 Last

Share
Profile

Follow
pembo111

2,193 Posts.

5

18/12/20

12:28

Post #: 49680296
Share

Originally posted by FieldRetriever: ↑

yeah there were a few mishaps. Plus when the co needed capital in the interim Boyd offered a lending facility (since transferred to a convertible note) so there hasn’t ever been much IR campaigning since IPO until a very small amount recently.

From listing they’ve had a series of bad PR because a couple of old partners of the Appointuit co they acquired (pre-listing) lodged legal claims for compensation that subsequently didn’t get anywhere but that was hanging over the co early.

Then when they first pursued the medicinal marijuana opportunity they partnered with a colourful character in NZ who ended up in the news for wrong reasons and it took them a few goes to part with him.

During the whole time i get the sense the management was trying to do too much at once and everywhere despite an objective to focus on profitability. When the CEO parted this year Boyd decided to get his own hands dirty in part i think to make sure the capital he’s sunk himself doesn’t go to waste but also because of the opportunity Covid presents. They were already transitioning their patient processing and monitoring platform to SaaS but he sees Covid as a real catalyst to accelerate e-health towards remote patient monitoring (RPM) - (more than just telehealth - Microsoft teams can be used for Telehealth). Hence he raised some capital to build the platform out and look at acquisitions if useful. He’s licensed in the LSH and MYQ tech for this objective as well.

I think he could have simply cleaned the business up and ensured it’s pathway to profitability before finding the next CEO but there were a couple of interviews after the cap raise where he really emphasised the opportunity RPM presented given their reputation and sticky network in UK in particular and the reference to NHS Community opportunity might have been a bit of a clue that he thinks he got the timing right.

If it weren’t Boyd I wouldn’t be interested but this could be a proper turnaround story pretty quickly. Sonic aside, he was one of the partners who brought Iridium (see Nasdaq) back from of bankruptcy after the tech bubble.

I’ve said before the medicinal marijuana capex to date is hard for me to appreciate but I’ve no doubt Boyd will make the most of that business stream as well. that seems to where all the interest of late has come from even though i think he sees the RPM platform as being The primary opportunity for growth.

Day trading a thin nano cap like this is pretty ballsy but if you’re stuck in the trade now it might be worth holding for a quarter or two to see if Boyd gets anywhere.

Expand

Appreciate the info. I have a rule that if I really want a stock I wait 2 or 3 days regardless, saved me a whole lot of red. Its definitely on the watchlist now though.

JHL Price at posting: 4.3¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 15 more messages in this thread...

First 17 Last

Add JTL (ASX) to my watchlist

Appreciate the info. I have a rule that if I really want a stock...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News